EP3288556 - ORALLY DISINTEGRATING COMPOSITIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.08.2019 Database last updated on 12.07.2024 | |
Former | Request for examination was made Status updated on 02.02.2018 | ||
Former | The international publication has been made Status updated on 04.11.2016 | Most recent event Tooltip | 30.08.2019 | Application deemed to be withdrawn | published on 02.10.2019 [2019/40] | Applicant(s) | For all designated states Dexcel Pharma Technologies Ltd. 1 Dexcel St. 3060000 Or Akiva / IL | [2018/10] | Inventor(s) | 01 /
MOSES-HELLER, Sheera 7 Hatzerot Haicarim 3030000 Atlit / IL | [2018/10] | Representative(s) | Becker Kurig & Partner Patentanwälte mbB Bavariastraße 7 80336 München / DE | [N/P] |
Former [2018/10] | Becker Kurig Straus Patentanwälte Bavariastrasse 7 80336 München / DE | Application number, filing date | 16786065.9 | 21.04.2016 | [2018/10] | WO2016IL50425 | Priority number, date | US201562154250P | 29.04.2015 Original published format: US 201562154250 P | [2018/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016174664 | Date: | 03.11.2016 | Language: | EN | [2016/44] | Type: | A1 Application with search report | No.: | EP3288556 | Date: | 07.03.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.11.2016 takes the place of the publication of the European patent application. | [2018/10] | Search report(s) | International search report - published on: | IL | 03.11.2016 | (Supplementary) European search report - dispatched on: | EP | 22.08.2018 | Classification | IPC: | A61K31/4184, A61K31/4439, A61K47/32, A61K47/36, A61K9/20, A61K9/50 | [2018/38] | CPC: |
A61K9/0056 (EP,IL,US);
A61K31/4184 (EP,IL,US);
A61K31/4439 (EP,IL,US);
A61K9/1623 (IL,US);
A61K9/1676 (IL,US);
A61K9/2072 (IL,US);
A61K9/2081 (EP,IL,US);
A61K9/2086 (IL,US);
A61K9/28 (IL,US);
A61K9/2886 (IL,US);
A61K9/5026 (EP,IL,US);
A61K9/5042 (EP,US);
|
Former IPC [2018/10] | A61K31/4184, A61K31/4439, A61K47/32, A61K47/36, A61K9/20 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/10] | Title | German: | ORAL ZERFALLENDE ZUSAMMENSETZUNGEN | [2018/10] | English: | ORALLY DISINTEGRATING COMPOSITIONS | [2018/10] | French: | COMPOSITIONS À DÉSINTÉGRATION PAR VOIE ORALE | [2018/10] | Entry into regional phase | 24.10.2017 | National basic fee paid | 24.10.2017 | Search fee paid | 24.10.2017 | Designation fee(s) paid | 24.10.2017 | Examination fee paid | Examination procedure | 24.10.2017 | Amendment by applicant (claims and/or description) | 24.10.2017 | Examination requested [2018/10] | 24.10.2017 | Date on which the examining division has become responsible | 19.03.2019 | Application deemed to be withdrawn, date of legal effect [2019/40] | 08.05.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/40] | Fees paid | Renewal fee | 28.02.2018 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.04.2019 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]EP1813275 (TEVA PHARMA [IL]) [X] 1-15 * paragraph [0048] * * the whole document * * tables 2,5 * [I] 1-15; | [T]WO2007093642 (FLAMEL TECH SA [FR], et al) [T] * claims 1,3,9,10 *; | [XI]EP1837016 (KRKA TOVARNA ZDRAVIL D D NOVO [SI]) [X] 1-15 * the whole document * * table 1 * * paragraphs [0062] , [0030] * [I] 1-15; | [XI]US2009068263 (ANTARKAR AMIT KRISHNA [IN], et al) [X] 1-15 * example 7 * * paragraph [0119] * [I] 1-15; | [XI]WO2010122583 (RUBICON RES PRIVATE LTD [IN], et al) [X] 1-15 * the whole document * * examples 1,6,8 * * claim 11 * [I] 1-15; | [I]US2011223244 (LIVERSIDGE GARY [US], et al) [I] 1-15 * claim 2 *; | [I]WO2012022498 (EVONIK ROEHM GMBH [DE], et al) [I] 1-15 * the whole document * * example 11 * * pages 42-43 *; | [XI]US2013202688 (ROY SUNILENDU BHUSHAN [IN], et al) [X] 1-15 * examples 2-5; claim 14 * * the whole document * [I] 1-15; | [I]US2014314846 (PENHASI ADEL [IL], et al) [I] 1-15 * the whole document * * example 11 * * paragraphs [0171] - [0184] * | International search | [Y]WO2006067599 (RANBAXY LAB LTD [IN], et al) [Y] 1-24 * p. 3-6, ex. 5, p. 15 *; | [XY]US2011223244 (LIVERSIDGE GARY [US], et al) [X] 1-10, 12-15, 17, 21, 23 * claims 1,15, 19, 25, table A, p. 5, ex. 4, ex, 14, para 0001, para 0053, para 0062-0063 claims 1,15, 19, 25, table A, p. 5, ex. 4, ex, 14, para 0001, para 0053, para 0062-0063 * [Y] 1-24; | [XY]WO2012022498 (EVONIK ROEHM GMBH [DE], et al) [X] 1-7, 10, 12, 15, 21, 23 * abstract, p.4, p. 11-14, p. 17-18, ex. 11,40 abstract, p.4, p. 11-14, p. 17-18, ex. 11,40 * [Y] 1-24; | [Y]WO2014032741 (EVONIK INDUSTRIES AG [DE]) [Y] 1-24 * p. 7-11, 13, ex. 26-28, p. 113-115 *; | [Y]US2014314846 (PENHASI ADEL [IL], et al) [Y] 1-24* Abstract, para 0038,0041,0093 * |